Merus NV
MRUS95.160USD
-0.020-0.02%
終値 11/06, 16:00（ET）15分遅れの株価
7.22B時価総額
損失額直近12ヶ月PER
詳細情報 Merus NV 企業名
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Merus NVの企業情報
企業コードMRUS
会社名Merus NV
上場日May 19, 2016
最高経営責任者「CEO」Dr. Sven Ante (Bill) Lundberg, M.D.
従業員数260
証券種類Ordinary Share
決算期末May 19
本社所在地Yalelaan 62
都市UTRECHT
証券取引所NASDAQ Global Market Consolidated
国Netherlands
郵便番号3584 CM
電話番号310302538800
ウェブサイトhttps://merus.nl/
企業コードMRUS
上場日May 19, 2016
最高経営責任者「CEO」Dr. Sven Ante (Bill) Lundberg, M.D.
Merus NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
198.74K
+55.46%
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Mr. Jason Haddock
Mr. Jason Haddock
Director
Director
--
--
Dr. Fabian Zohren, M.D., Ph.D
Dr. Fabian Zohren, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Maxine Gowen, Ph.D.
Dr. Maxine Gowen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Victor Sandor, M.D.
Dr. Victor Sandor, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
198.74K
+55.46%
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Mr. Jason Haddock
Mr. Jason Haddock
Director
Director
--
--
Dr. Fabian Zohren, M.D., Ph.D
Dr. Fabian Zohren, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, Aug 15
更新時刻: Fri, Aug 15
株主統計
種類
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
8.20%
Paradigm BioCapital Advisors LP
5.65%
RTW Investments L.P.
5.27%
Wellington Management Company, LLP
4.91%
Commodore Capital LP
4.65%
他の
71.32%
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
8.20%
Paradigm BioCapital Advisors LP
5.65%
RTW Investments L.P.
5.27%
Wellington Management Company, LLP
4.91%
Commodore Capital LP
4.65%
他の
71.32%
種類
株主統計
比率
Investment Advisor/Hedge Fund
36.78%
Hedge Fund
34.50%
Investment Advisor
25.54%
Corporation
1.93%
Venture Capital
1.77%
Research Firm
1.13%
Private Equity
0.93%
Individual Investor
0.37%
Pension Fund
0.36%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
431
77.28M
101.92%
-5.29M
2025Q2
411
75.46M
99.77%
-10.50M
2025Q1
420
74.82M
101.12%
-10.15M
2024Q4
398
74.69M
108.18%
-7.45M
2024Q3
373
72.99M
107.03%
-6.71M
2024Q2
355
69.91M
103.77%
+7.77M
2024Q1
315
57.35M
97.63%
-5.32M
2023Q4
282
57.36M
99.41%
-5.55M
2023Q3
268
57.60M
100.50%
+2.76M
2023Q2
260
49.90M
100.83%
+114.35K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Fidelity Management & Research Company LLC
6.22M
8.2%
+593.98K
+10.56%
Jun 30, 2025
Paradigm BioCapital Advisors LP
4.28M
5.65%
+727.89K
+20.48%
Jun 30, 2025
RTW Investments L.P.
4.00M
5.28%
-168.84K
-4.05%
Jun 30, 2025
Wellington Management Company, LLP
3.73M
4.92%
-991.45K
-21.01%
Jun 30, 2025
Commodore Capital LP
3.52M
4.65%
-947.84K
-21.19%
Jun 30, 2025
Deerfield Management Company, L.P.
3.38M
4.47%
+210.70K
+6.64%
Jun 30, 2025
Avoro Capital Advisors LLC
3.16M
4.16%
+155.56K
+5.19%
Jun 30, 2025
T. Rowe Price Associates, Inc.
2.26M
2.98%
+1.17M
+106.44%
Jun 30, 2025
Holocene Advisors, LP
2.23M
2.94%
+351.62K
+18.77%
Jun 30, 2025
Westfield Capital Management Company, L.P.
2.04M
2.69%
+541.17K
+36.05%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Harbor Health Care ETF
4.61%
ALPS Medical Breakthroughs ETF
4.1%
Tema Oncology ETF
3.91%
AltShares Merger Arbitrage ETF
3.3%
NYLI Merger Arbitrage ETF
3.1%
Goldman Sachs Hedge Industry VIP ETF
2.89%
First Trust IPOX Europe Equity Opportunities ETF
2.59%
Simplify Health Care ETF
2.48%
Invesco Dorsey Wright Healthcare Momentum ETF
1.5%
AltShares Event-Driven ETF
1.39%
詳細を見る
Harbor Health Care ETF
比率4.61%
ALPS Medical Breakthroughs ETF
比率4.1%
Tema Oncology ETF
比率3.91%
AltShares Merger Arbitrage ETF
比率3.3%
NYLI Merger Arbitrage ETF
比率3.1%
Goldman Sachs Hedge Industry VIP ETF
比率2.89%
First Trust IPOX Europe Equity Opportunities ETF
比率2.59%
Simplify Health Care ETF
比率2.48%
Invesco Dorsey Wright Healthcare Momentum ETF
比率1.5%
AltShares Event-Driven ETF
比率1.39%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
